Create a narrative

Cytosorbents Community

NasdaqCM:CTSO Community

1 Narratives written by author
0 Comments on narratives written by author
2 Fair Values set on narratives written by author

Create a narrative

AN

AnalystConsensusTarget

Consensus Narrative from 3 Analysts

FDA And Health Canada Decisions Will Advance DrugSorb-ATR Launch

Key Takeaways Regulatory decisions on DrugSorb-ATR could drive significant revenue growth, especially in the U.S. and Canada, with a large market opportunity. International revenue grows due to increased adoption and local reimbursements, complementing efforts in Germany and supporting overall revenue expansion.

US$5.00

FV

81.8% undervalued

22.40%

Revenue growth p.a.

0

0

2

5 days ago